Vanguard Group
MIRO

Vanguard Group’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

Vanguard Group’s Portfolio MIRO Stock Details MIRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-658,548
Closed -$863K – 4540
2023
Q3 		$863K Buy
658,548
+9,293
+1% +$13.6K ﹤0.01% 3888
2023
Q2 		$1.14M Hold
649,255
– – ﹤0.01% 3860
2023
Q1 		$1.09M Buy
649,255
+14,100
+2% +$36.7K ﹤0.01% 3888
2022
Q4 		$1.9M Buy
635,155
+205,864
+48% +$808K ﹤0.01% 3676
2022
Q3 		$1.88M Buy
429,291
+256,744
+149% +$829K ﹤0.01% 3769
2022
Q2 		$689K Buy
172,547
+2,681
+2% +$10.3K ﹤0.01% 4202
2022
Q1 		$673K Buy
169,866
+15,490
+10% +$57.7K ﹤0.01% 4320
2021
Q4 		$724K Buy
+154,376
New +$1.1M ﹤0.01% 4354

Vanguard Group's MIRO Position: Q4 2023 in Review

Vanguard Group sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q4 2023, closing a stake of 658,548 shares — an estimated $863K sold.

Vanguard Group first reported a position in MIRO in Q4 2021 and held it in 8 quarters. The position peaked at $1.9M in Q4 2022. 0 funds tracked by Wall St. Rank hold MIRO as of Q4 2023.

  • Vanguard Group reported no remaining Miromatrix Medical Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Vanguard Group sold 658,548 Miromatrix Medical Inc. Common Stock shares in Q4 2023, an estimated $863K.
  • Vanguard Group first reported a position in Miromatrix Medical Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • Vanguard Group's Miromatrix Medical Inc. Common Stock position peaked at $1.9M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q4 2023.

Based on Vanguard Group's 13F filing for Q4 2023, filed 14 Feb 2024.